Cellebrite DI Ltd.

Symbol: CLBT

NASDAQ

12.29

USD

Market price today

  • -27.0203

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 2.43B

    MRK Cap

  • 0.00%

    DIV Yield

Cellebrite DI Ltd. (CLBT) Financial Statements

On the chart you can see the default numbers in dynamics for Cellebrite DI Ltd. (CLBT). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Cellebrite DI Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019

balance-sheet.row.cash-and-short-term-investments

0302.9183.6181.6
237.6
200.3

balance-sheet.row.short-term-investments

0113.49635.6
108.9
123.7

balance-sheet.row.net-receivables

077.378.867.5
66.3
44.2

balance-sheet.row.inventory

010.510.26.5
4.8
4

balance-sheet.row.other-current-assets

025.817.112.8
3
1.7

balance-sheet.row.total-current-assets

0416.5295.9273.2
324.3
261.9

balance-sheet.row.property-plant-equipment-net

030.232.916.8
16.1
14.8

balance-sheet.row.goodwill

026.826.826.8
9.5
0

balance-sheet.row.intangible-assets

010.611.311.2
6.6
0

balance-sheet.row.goodwill-and-intangible-assets

037.438.138.1
16.1
0

balance-sheet.row.long-term-investments

028.922.10
0
0

balance-sheet.row.tax-assets

014.512.59.8
7.4
3.1

balance-sheet.row.other-non-current-assets

012.91.72
0.6
0.4

balance-sheet.row.total-non-current-assets

0123.9107.466.6
40.1
18.4

balance-sheet.row.other-assets

0000
0
0

balance-sheet.row.total-assets

0540.4403.3339.8
364.4
280.2

balance-sheet.row.account-payables

08.34.69.5
4.7
5.4

balance-sheet.row.short-term-debt

0550
0
0

balance-sheet.row.tax-payables

00.82.98.2
6.6
1.3

balance-sheet.row.long-term-debt-total

09.210.4-2.7
-2.8
0

Deferred Revenue Non Current

047.142.236.4
33.4
18.9

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-

balance-sheet.row.other-current-liab

04445.554
48.6
24

balance-sheet.row.total-non-current-liabilities

0252.4121.7226.6
141.2
122.3

balance-sheet.row.other-liabilities

0000
0
0

balance-sheet.row.capital-lease-obligations

09.215.40
0
0

balance-sheet.row.total-liab

0506.2329.4413.1
300.6
221.4

balance-sheet.row.preferred-stock

0000
101.2
101.2

balance-sheet.row.common-stock

0000
0
0

balance-sheet.row.retained-earnings

0118.1199.278.4
28.3
32.6

balance-sheet.row.accumulated-other-comprehensive-income-loss

01.10.31.4
1.3
0.8

balance-sheet.row.other-total-stockholders-equity

0-85-125.7-153.2
-67.1
-75.7

balance-sheet.row.total-stockholders-equity

034.273.9-73.3
63.8
58.8

balance-sheet.row.total-liabilities-and-stockholders-equity

0540.4403.3339.8
364.4
280.2

balance-sheet.row.minority-interest

0000
0
0

balance-sheet.row.total-equity

034.273.9-73.3
63.8
58.8

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-

Total Investments

0142.3118.135.6
108.9
123.7

balance-sheet.row.total-debt

014.115.40
0
0

balance-sheet.row.net-debt

0-175.4-72.3-146
-128.7
-76.5

Cash Flow Statement

The financial landscape of Cellebrite DI Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019

cash-flows.row.net-income

0-81.1120.871.4
5.8
-1.9

cash-flows.row.depreciation-and-amortization

0109.27.1
5.9
4.1

cash-flows.row.deferred-income-tax

05.1-2.4-1.6
-2.8
-1.7

cash-flows.row.stock-based-compensation

01913.76.5
7.3
12.8

cash-flows.row.change-in-working-capital

038.5-2.820.6
49.8
2.7

cash-flows.row.account-receivables

02.3-12.9-2
-19.7
-12.2

cash-flows.row.inventory

00.2-3.7-1.8
-0.7
0.8

cash-flows.row.account-payables

04.4-5.54.2
-1.4
1

cash-flows.row.other-working-capital

031.619.220.2
71.6
13.2

cash-flows.row.other-non-cash-items

0110.5-117.9-67.9
0.6
0.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-7.9-9.1-8.1
-6.2
-6.2

cash-flows.row.acquisitions-net

00106.6-20
-15
0

cash-flows.row.purchases-of-investments

0-55.3-165.4-21
-138.5
0

cash-flows.row.sales-maturities-of-investments

056.383.294.3
153.3
0

cash-flows.row.other-investing-activites

0-15.6-106.60
0
-40.5

cash-flows.row.net-cash-used-for-investing-activites

0-22.5-91.245.2
-6.4
-46.7

cash-flows.row.debt-repayment

0-4.400
-1.5
0

cash-flows.row.common-stock-issued

021.8142.3
1.5
0

cash-flows.row.common-stock-repurchased

0000
-0.1
-0.8

cash-flows.row.dividends-paid

000-100
-10
-25

cash-flows.row.other-financing-activites

04.41429.3
1.5
101.3

cash-flows.row.net-cash-used-provided-by-financing-activities

021.814-68.4
-8.6
75.5

cash-flows.row.effect-of-forex-changes-on-cash

00.6-1.6-0.8
0.7
-0.1

cash-flows.row.net-change-in-cash

0101.9-58.312.1
52.2
44.9

cash-flows.row.cash-at-end-of-period

0189.587.6146
133.8
81.7

cash-flows.row.cash-at-beginning-of-period

087.6146133.8
81.7
36.8

cash-flows.row.operating-cash-flow

0102.120.636.1
66.5
16.1

cash-flows.row.capital-expenditure

0-7.9-9.1-8.1
-6.2
-6.2

cash-flows.row.free-cash-flow

094.111.527.9
60.3
9.9

Income Statement Row

Cellebrite DI Ltd.'s revenue saw a change of NaN% compared with the previous period. The gross profit of CLBT is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019

income-statement-row.row.total-revenue

0325.1270.7246.2
194.9
171.9

income-statement-row.row.cost-of-revenue

053.250.742.6
37.9
35.8

income-statement-row.row.gross-profit

0271.9219.9203.7
157
136

income-statement-row.row.gross-profit-ratio

0000
0
0

income-statement-row.row.research-development

0---
-
-

income-statement-row.row.selling-general-administrative

0---
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-

income-statement-row.row.other-expenses

0000
2.3
0.8

income-statement-row.row.operating-expenses

0238.6218.9189.9
147.8
137.6

income-statement-row.row.cost-and-expenses

0291.8269.6232.4
185.7
173.4

income-statement-row.row.interest-income

010.71.668.5
2.7
3.5

income-statement-row.row.interest-expense

00.8119.70.6
1.4
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-

income-statement-row.row.total-other-income-expensenet

0-108.8119.768.5
2.2
2.7

income-statement-row.row.ebitda-ratio-caps

0---
-
-

income-statement-row.row.other-operating-expenses

0000
2.3
0.8

income-statement-row.row.total-operating-expenses

0-108.8119.768.5
2.2
2.7

income-statement-row.row.interest-expense

00.8119.70.6
1.4
0

income-statement-row.row.depreciation-and-amortization

0109.27.1
6.3
4.1

income-statement-row.row.ebitda-caps

0---
-
-

income-statement-row.row.operating-income

033.3113.8
9.2
-1.3

income-statement-row.row.income-before-tax

0-75.6120.882.3
11.4
1.4

income-statement-row.row.income-tax-expense

05.5010.9
5.6
3.3

income-statement-row.row.net-income

0-81.1120.871.4
5.8
-1.9

Frequently Asked Question

What is Cellebrite DI Ltd. (CLBT) total assets?

Cellebrite DI Ltd. (CLBT) total assets is 540397000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.836.

What is company free cash flow?

The free cash flow is 0.484.

What is enterprise net profit margin?

The net profit margin is -0.249.

What is firm total revenue?

The total revenue is 0.102.

What is Cellebrite DI Ltd. (CLBT) net profit (net income)?

The net profit (net income) is -81100000.000.

What is firm total debt?

The total debt is 14129000.000.

What is operating expences number?

The operating expences are 238597000.000.

What is company cash figure?

Enretprise cash is 0.000.